secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001437749-24-003376
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics amends prior advances and secures $250K new advances; extends closing deadline to March 31, 2024
--------------------------------------------------------------------------------

- Prior advances of $500K amended; closing deadline extended from Feb 29 to Mar 31, 2024.
- If no closing by Mar 31, lenders may elect to receive pre-funded warrants and common warrants for 484,966 shares each.
- If Nasdaq listing not approved by Mar 31, company must issue additional warrants for 121,241 shares each by Apr 2.
- Two additional purchasers advanced $250K in new advances, subject to same New Advance Terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924003376/0001437749-24-003376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924003376/arch20240207_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-003376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer